Note: Ingredients listed on restricted chemical lists
EC/CAS
7732-18-5
Name of the chemical
Water, distilled, conductivity or of similar purity H2O
Concentration
N/A
General Information
Revision date
2023-01-13
Product name
6-amino-9-β -D-ribofuranosyl-9H-purine
Chemical name
6-amino-9-β -D-ribofuranosyl-9H-purine
Manufacturer Name
Akorn
Icons in SDS
Company Information
company name
Akorn
Section 2
Principle Routes of Exposure
Adenosine injection may be absorbed via contact with skin or eyes, inhalation of aerosols or accidentally ingested. Carcinogenicity: NTP: No IARC: No
Health hazards
Acute and Chronic) Adenosine Injection is an anti-arrhythmic cardiac depressant that is used in treating certain heart conditions. Minimal adverse effect should occur from routine use with this product. Acute signs and symptoms of exposure may include dizziness, nausea, vomiting, flushing of skin, irregular heartbeat, pain in chest, fluctuation in blood pressure and numbness or tingling in arms. May cause irritation to eyes, skin, and respiratory tract. Product may cause allergic reaction if inhaled or absorbed through the skin. Adenosine has low chronic toxicity.